Psyched Wellness Ltd.
PSYCF
$0.0131
-$0.0006-4.38%
| Weiss Ratings | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.53 | |||
| Price History | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -14.38% | |||
| 30-Day Total Return | -12.67% | |||
| 60-Day Total Return | -6.43% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 1.55% | |||
| 1-Year Total Return | -61.92% | |||
| 2-Year Total Return | -76.81% | |||
| 3-Year Total Return | -81.58% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -85.44% | |||
| 52-Week Low % Change | 31.00% | |||
| Price | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.09 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Nov 01, 2024 | |||
| 52-Week High Price (Date) | May 15, 2024 | |||
| Valuation | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.00M | |||
| Enterprise Value | -1.78M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -20.81% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 8.73 | |||
| Price/Book (Q) | 0.65 | |||
| Enterprise Value/Revenue (TTM) | -3.97 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | 0.50 | |||
| Enterprise Value/EBIT | 0.50 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 288.07M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 647 400 8494 | |||
| Address | 77 King Street West Toronto, ON M5K 1G8 | |||
| Website | psyched-wellness.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -789.42% | |||
| Profit Margin | -772.17% | |||
| Management Effectiveness | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -36.54% | |||
| Return on Equity | -- | |||
| Income Statement | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 449.20K | |||
| Total Revenue (TTM) | 449.20K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 293.30K | |||
| EBITDA (TTM) | -3.54M | |||
| EBIT (TTM) | -3.55M | |||
| Net Income (TTM) | -3.47M | |||
| Net Income Avl. to Common (TTM) | -3.47M | |||
| Total Revenue Growth (Q YOY) | 146.71% | |||
| Earnings Growth (Q YOY) | -206.97% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -51.85% | |||
| Balance Sheet | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.10M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 5.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.84M | |||
| Current Ratio (Q) | 32.529 | |||
| Book Value Per Share (Q) | $0.02 | |||
| Total Assets (Q) | 6.03M | |||
| Total Current Liabilities (Q) | 183.70K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 183.70K | |||
| Total Common Equity (Q) | 5.84M | |||
| Cash Flow | PSYCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 11.70K | |||
| Cash from Financing (TTM) | 2.48M | |||
| Net Change in Cash (TTM) | 13.90K | |||
| Levered Free Cash Flow (TTM) | -1.22M | |||
| Cash from Operations (TTM) | -2.49M | |||
